Top Markets
#1 Arowana Arowana +40.15%
#2 Tutorial Tutorial +33.39%
#3 Fabric Protocol Fabric Protocol +31.03%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +28.74%
#5 Bitcoin Cash Bitcoin Cash +28.40%
#6 Ethena Staked ENA Ethena Staked ENA +26.40%
#7 The Black Bull The Black Bull +25.66%
#8 Audiera Audiera +25.51%
#9 Zora Zora +25.16%
#10 GALA GALA +23.86%
Coin of the day
Arowana Arowana
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Clasificación en acciones #24698
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Precio por acción
$0.95011029
Última sincronización: 2023-06-28
Capitalización bursátil
$57.72M
Cambio (1 día)
8.53%
Cambio (1 año)
0.00%
País
FR
Comercio ERYTECH Pharma S.A. (ERYP)

Categoría

Healthcare
Ingresos de ERYTECH Pharma S.A. (ERYP)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de ERYTECH Pharma S.A., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de ERYTECH Pharma S.A. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH